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The extract of Citrus reticulata has been studied for its biological 
activities, due to its citrus flavonoid content. The extract and its flavonoid 
compounds exhibit growth inhibition property in several cancer cell lines and 
in vivo models. Conversely, the extract can also induce cell proliferation and 
angiogenesis, and shows estrogenic effects by in vitro and in vivo. Because of 
the contrasting effects that depend on the concentration or dosage, the 
precise action of the extract and its flavonoids need to be elucidated in various 
cell types. The objective of this study is to evaluate the effect of Citrus 
reticulata peel extract (Citrus extract) and hesperidin, a citrus flavonoid, on 
the modulation of cell proliferation in the RAW 264.7 macrophage cell line. 
Cell viability under Citrus extract or hesperidin treatment was assessed by 
using the MTT assay. The expression of interleukin-10 (IL-10), an anti-
inflammatory cytokine, modulated by Citrus extract was also examined by 
immunostaining. Low concentrations of Citrus extract at 1 and 100μg/mL 
were able to induce cell proliferation, although in significant, as shown by cell 
viability of 138 and 114%, respectively. At higher concentrations of 500, 750, 
and 1000μg/mL, Citrus extract decreased cell viability significantly by up to 
64, 46, and  36%, respectively.  Accordingly, hesperidin  at low (3.1μg/mL 
−61.1μg/mL) concentration increased cell viability significantly  by up to 116-
136% where as high (152.6203μg/mL–305.3203μg/mL) concentration 
reduced cell viability significantly by up to 10-61%. The value of the 50% 
inhibitory concentration (IC50) of Citrus extract was more than three times 
higher (756μg/mL) than that of hesperidin (203μg/mL = 332μM). Additionally, 
250μg/mL of Citrus extract was able to induce IL-10 expression compared to 
control. These results demonstrated that Citrus extract and hesperidin 
exerted a biphasic effect on macrophage cells. The future development of Citrus 
extract as a co-chemotherapeutic, anticancer, or immunomodulatory agent 
should include careful consideration of its biphasic effect on each cell type. 
Keywords: Citrus reticulata, hesperidin, macrophage RAW 264.7 cell, 
proliferation, interleukin-10 (IL-10) 
 
 
INTRODUCTION  
Citrus plants (family: Rutaceae) have 
attracted researchers’ attention due to their 
biological activities since the early 18th century 
(Manthey et al., 2001). Their phytochemical health-
promoting properties are mainly based on the anti-
oxidant activities of flavonoid compounds that 
contribute to the cardiovascular disease and cancer 
prevention, anti-inflammatory, antiviral, and 
antimicrobial properties of citrus (Barreca et al., 
2017; Benavente-Garcia et al., 1997). Citrus species 
contain a variety of flavonoids, namely flavonones, 
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flavons, and flavonols (Benavente-García et al., 
1997). Hesperidin, a flavonone glycoside, is a major 
flavonoid compound in Citrus reticulata (reviewed 
in Barreca et al., 2017). The first description of 
hesperidin by Lebreton in 1828 marked the 
beginning of researchers’ vast interest in citrus 
flavonoids (reviewed in Manthey et al., 2001). As a 
fruit crop that is abundantly cultivated and 
consumed across the globe, citrus fruits generate a 
large amount of waste every year (Sharma et al., 
2017). Citrus peels are one of the solid citrus waste 
products that need to be managed. Since 2007, the 
Cancer Chemoprevention Research Center, Faculty 
of Pharmacy, Universitas Gadjah Mada (UGM), 
Indonesia has been exploring the extract of citrus 
peels in order to reveal its chemopreventive 
properties and, at the same time, to increase the 
utility of citrus waste (reviewed in Meiyanto et al., 
2012). One of the studies was focused on the 
ethanolic extract of Citrus reticulata, commonly 
known as tangerine or mandarin, which has been 
shown to contain flavonoids (Armandari, 2010; 
Meiyanto et al., 2011) (Table I). In addition, 
hesperidin, as one of the main compounds, has 
been studied (Table I).  
In vitro, it induces cell proliferation                         
and angiogenesis in MCF-7 breast or WiDr colon 
cancer cells at concentrations of 10−1500μg/mL 
(Ardiani et al., 2008; Puspita et al., 2008;                     
Yunas et al., 2007) but can suppress MCF-7 cell 
Table I. Biological activities of Citrus reticulata peel extract (Citrus extract) and hesperidin 
 
Material Experimental design Biological activity 
Concentration 
/dosage 
Reference 
Citrus 
extract 
In vitro assay in MCF-7 
breast cancer cell line 
Increases selectivity for 
doxorubicin 
 
 
(Yunas et al., 
2007) 
Single treatment induces cell 
proliferation 
50-400μg/mL 
bFGF-induced chicken 
embryo chorio-allantoic 
membrane 
Anti-angiogenesis 150-600μg (Chrisnanto et 
al., 2008) 
In vitro assay in WiDr 
colon cancer cell line 
Induces cell proliferation and 
COX-2 expression 
10-500μg/mL (Ardiani et al., 
2008) 
Induces VEGF expression 1.500-μg/mL (Puspita et al., 
2008) 
Ovariectomized rats Estrogenic (modulates blood 
cholesterol profile and increases 
bone density) 
500-1.000 
mg/kg BW 
(Adelina et al., 
2015) 
DMBA-induced rats Inhibits breast epithelial cell 
proliferation (reduces c-Myc 
expression) 
750-
1.500mg/kg BW 
(Supriyati et al., 
2008) 
Inhibits hepatic cell proliferation 
(reduces c-Myc expression) 
750-
1.500mg/kg BW 
(Meiyanto et al., 
2012) 
Hesperidin In vitro assay in MCF-7 
breast cancer cell line 
Increases selectivity for 
doxorubicin 
 (Hermawan et 
al., 2010) 
Single treatment induces cell 
proliferation 
5-100μM 
In vitro assay in T47D 
breast cancer cell line 
Cytotoxic IC50 200μM (Setiawati et al., 
2011) 
In vitro assay in HeLa 
cervical cancer cell line 
Cytotoxic IC50 48μM (Kusharyanti et 
al., 2011) 
In vitro assay in WiDr 
colon cancer cell line 
Increases selectivity for 
doxorubicin 
 
 
(Gilang et al., 
2012) 
Single treatment is not cytotoxic 5–200 μM 
In vitro assay in MCF-
7/HER2 breast cancer 
cell line 
Increases selectivity for 
doxorubicin 
IC50 11 μM (Febriansah et 
al., 2014) 
 
Acronyms: bFGF, basic fibroblast growth factor; DMBA = 7,12-dimethylbenz(a)anthracene 
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proliferation when combined with doxorubicin,         
a   cytostatic   agent   (Yunas et al., 2007)   (Table I).  
In vivo, 150-600μg Citrus extract shows anti-
angiogenic activities (Chrisnanto et al., 2008) and 
suppresses epithelial breast and hepatic cell 
proliferation in rats with chemically induced 
cancer at 750-1500mg/kg BW (Supriyati et al., 
2008; Meiyanto et al., 2011). In the same manner as 
Citrus extract, hesperidin also displays differing 
properties depending on its concentration and the 
cell type. Hesperidin (5-200μM) increases cell 
viability in MCF-7 and WiDr cells but decreases cell 
viability more effectively in combination with an 
anticancer agent than the anticancer agent alone 
(Gilang et al., 2012; Hermawan et al., 2010). In the 
other cancer cell lines, T47D breast, HeLa cervix, 
and MCF-7 with HER2 over-expression (MCF-7 
/HER2), hesperidin exhibits an IC50 value varying 
from 11 to 200μM (Febriansah et al., 2014; 
Kusharyanti et al., 2011; Setiawati et al., 2011). The 
effect of Citrus extract on MCF-7/HER2 is contrary 
to the estrogenic effect seen in ovariectomized mice 
(Adelina et al., 2015). In summary, Citrus extract 
and hesperidin may act differently depending on 
the concentration and the cell type. The dual or 
biphasic effect of these compounds on cell 
proliferation will influence whether the expected 
effect on cells is antiproliferative or proliferative. 
Therefore, the precise action of Citrus extract and 
citrus flavonoids need to be elucidated in various 
cell types.  Besides the exploration of its anticancer 
potency, citrus and citrus flavonoids have also been 
studied for their anti-inflammatory activities 
(Manthey et al., 2001). Our group’s work has been 
focused mainly on cancer cells, not on normal or 
inflammation-related cells (Table I). To our 
knowledge, no study has yet addressed the dual 
effect of citrus extract or citrus flavonoids on cell 
proliferation. Hence, an investigation of Citrus 
extract and citrus flavonoids on normal or 
inflammatory-related cells, i.e., macrophages, is 
important, especially considering the probability of 
their contradictory concentration-dependent effect. 
In this study, we evaluate the effect of ethanolic 
extract from Citrus reticulata peel (Citrus extract) 
and hesperidin at various concentrations on the 
modulation of cell proliferation in the RAW 264.7 
macrophage cell line. We reveal that both Citrus 
extract and hesperidin show a biphasic effect on 
RAW 264.7 macrophage cell viability. Additionally, 
Citrus extract at a moderate tested concentration 
can induce the expression of interleukin-10 (IL-10), 
an anti-inflammatory cytokine.    
 
MATERIAL AND METHODS 
Preparation of Citrus extract 
Citrus reticulata fruits were obtained                 
from Kalisoro, Tawangmangu, Central Java, 
Indonesia in September and were identified                        
in the Laboratory of Pharmacognosy, Department 
of Pharmaceutical Biology, Faculty of Pharmacy, 
Universitas Gadjah Mada (UGM). Healthy, green, 
mature but unripe fruits were washed, and                         
the peels were collected and air dried                 
without direct sunlight. Dried peels were 
powdered and macerated in 70% ethanol (Merck, 
Darmstadt, Germany) (10L for 1kg powder)                          
for 5 days as previously described (Adelina et al., 
2008). The ethanolic fraction was separated                    
and evaporated in a rotary vacuum evaporator 
until a brown viscous extract was obtained                
(yield was 3.21% (b/b)) (Armandari, 2010).                     
The obtained extract was then identified by thin 
layer chromatography to detect flavonoid 
components as previously described (Meiyanto et 
al., 2011). After citrobroric treatments, positive 
spots indicating flavonoids were developed        
under 245 and 366nm UV lights (Armandari, 
2010). This extract is heretofore referred to as 
“Citrus extract.” 
 
Preparation of tested materials 
Citrus extract was first diluted in                
dimethyl sulfoxide (DMSO) (99.5% pro GC,               
Sigma Aldrich, Germany) as a stock solution of 
50mg/mL and then serially diluted in culture 
medium to reach the designated concentrations (1; 
5; 10; 25; 50; 75; 100; 250; 500; 750; and 
1,000μg/mL) with a maximum final DMSO 
concentration of 2% (v/v). The same preparation 
procedure was also carried out for hesperidin 
(Sigma Aldrich, Germany), a citrus flavonoid,                      
as a comparison (1, 5, 10, 25, 50, 100, 250, and 
500μM). 
 
Cell culture 
The murine monocyte macrophage RAW 
264.7 cell line was a gift from Prof. Tatsuo Takeya 
(Nara Institute of Science and Technology, Japan). 
Cells were cultured in Minimum Essential Media 
(Gibco, USA) supplemented with 10% (v/v) 
Newborn Calf Serum (NBCS) (Gibco, USA) and 2% 
(v/v) penicillin-streptomycin (Gibco, USA) in a 
37ᵒC, 5% CO2 incubator and grown to confluence in 
75cm3 tissue culture flasks. After they reached 80% 
confluence, cells were scraped and used for 
experiments. 
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Cell viability assay 
Cells (5 × 103 cells/well) were plated in 96-
well plates and cultured in a complete medium for 
48h. The medium was then replaced with a medium 
containing various concentrations of Citrus extract 
or hesperidin and incubated for 24h. Cell viability 
was assessed by the MTT method as previously 
described (Ikawati et al., 2018) and carried out in 
at least triplicate for each experiment. Briefly, the 
absorbance at 595nm of diluted formazan after 
addition of 0.5mg/mL 3-(4,5-dimethylthiazolyl-2)-
2,5-diphenyltetrazolium bromide (MTT) (Sigma 
Aldrich, Germany) in phosphate-buffered saline 
(PBS) followed by stopper solutions (10% SDS 
(Merck, Germany) in 0.1NHCl (Merck, Germany)) 
were measured in a microplate reader (Bio-Rad, 
Japan). The detailed step-by-step protocol is 
described in Armandari (2010). Untreated cells 
served as a control, while wells without cells served 
as a blank. The percent cell viability and the IC50 
value were calculated as (absorbance of treated 
cells − absorbance of blank)/(absorbance of 
control − absorbance of blank) × 100% and by 
linear regression analysis as follows: cell viability 
(%, y axis) vs log concentration (μg/mL or μM, x 
axis) (Ikawati et al., 2018),  including all tested 
dosage of the concentration series). Data are 
presented as the mean of two or three 
measurements per condition per experiment. 
 
Immunostaining 
Immunocytochemistry with an anti-IL-10 
mouse monoclonal antibody (Dako) was carried 
out by the avidin-biotin complex method as 
previously described (Ardiani et al., 2008). Cells (1 
x 105 cells/well) were plated on coverslips in a 24-
well plate until they reached 80% confluence. Cells 
were then incubated with Citrus extract at the 
designated concentrations for 15h. After removal 
of the medium, cells were washed with cold PBS, 
and then were fixed in cold methanol for 10min at 
-20ᵒC. The endogenous peroxidase activity was 
blocked with hydrogen peroxide, and nonspecific 
sites were blocked with normal goat serum 
(Novocastra), for 10min each at room temperature, 
followed by incubation in the primary antibody, 
anti-IL-10 (1:50), overnight at 4ᵒC. After washing 
with PBS, cells were incubated in IgG biotinylated 
universal secondary antibody (Novocastra)                       
for 10min. Following washing, cells were incubated 
with streptavidin-peroxidase complex reagent 
(Novocastra) for 10min and then incubated with 
3,3-diaminobenzinidine (DAB) substrate solution 
(Novocastra) for 2-10min to visualize the bound 
biotin. Cover slips were washed in distilled water 
and counterstained with Mayer’s hematoxylin 
(Dako) for 1-3min. Cells were dehydrated in 
ethanol, cleared in xylene, and cover slips were 
mounted with a mounting medium. Protein 
expression was observed qualitatively with a light 
microscope (Olympus). A stained cover slip 
without primary antibodies served as a control.  
 
Statistical analysis 
Data are presented as mean ± standard 
deviation (SD) and were analyzed for significance 
using the Student’s t-test. Values of p <0.05 were 
considered to indicate significance.  
 
RESULTS AND DISCUSSION 
Higher, but not lower, concentrations of Citrus 
extract decrease RAW 264.7 cell viability  
To examine the inhibition or induction of cell 
proliferation, RAW 264.7 cells were treated with a 
series of concentrations of Citrus extract, in the 
range from 1 to 1,000μg/mL, for 24h. As expected, 
lower concentrations of Citrus extract did not affect 
cell morphology. The cell morphology at lower 
concentrations (i.e., 10μg/mL and 50μg/mL) 
appeared the same as that of control cells                          
(Figure 1A). Moreover, the cell density increased 
after treatment with 50μg/mL extract. In contrast, 
at higher concentrations, starting at 500μg/mL, 
more cells appeared rounder and less flattened out 
in the well. These morphological observations 
imply a biphasic effect of Citrus extract. 
After 24h of incubation with Citrus extract, 
cell viability was assayed by the MTT method. The 
higher concentrations of Citrus extract (500μg/mL, 
750μg/mL, and 1000μg/mL) were able to decrease 
cell viability significantly (64%, 46%, and 36%, 
respectively, compared with 100% in the control 
without Citrus extract treatment) (Figure 1B). The 
cell viability in the presence of 250μg/mL Citrus 
extract was 96%, while lower concentrations 
increased the cell viability, though not significantly, 
ranging from 108% to 138%. The highest cell 
viability was given by the lowest tested 
concentration, 1μg/mL. Thus, Citrus extract 
demonstrated a biphasic effect on RAW 264.6 
macrophage cell proliferation.           
 
Biphasic effects of hesperidin on RAW 264.7 cell 
viability  
Hesperidin is one of the citrus flavonoids, a 
major compound in Citrus extract or citrus in 
general. Therefore, a similar cell viability assay was 
also carried out for hesperidin to determine 
Biphasic Effects of Citrus reticulata’s Extract and Hesperidin  
264   Volume 30 Issue 4 (2019) 
whether this compound would exert a similar 
biphasic effect to the extract. A series of 
concentrations varying from 1μM to 500μM (equal 
to 0.6μg/mL−305.3μg/mL) was used (Figure 2). 
The lowest tested concentration did not 
significantly affect cell viability. However, at 
5−100μM, hesperidin increased cell viability 
significantly (116%−136% compared with 100% 
in the control without hesperidin treatment). At 
higher concentrations, hesperidin decreased cell 
 
 
Figure 1. Effects of Citrus extract on cell viability in RAW 264.7 macrophage cells. Cells were treated with a 
concentration series of Citrus extract, incubated for 24h, and then assayed by MTTassay in pentaplicate.              
A. Cell morphology and density were observed under a microscope, and representative pictures are 
presented. Scale bars = 100μm. B. The graph of Citrus extract treatment demonstrated a biphasic effect on 
cell viability. The experiments were carried out twice, and the graph represents  means ±=SD (n=2). 
Statistical significance was determined by means of the Student’s t-test. Asterisks indicate a significant 
decrease (*; p<0.05. **; p<0.01) in cell viability compared with the control. 
 
 
 
Figure 2. Effects of hesperidin on cell viability in RAW 264.7 macrophage cells. Cells were treated with a 
concentration series of hesperidin, incubated for 24h, and then assayed by MTT assay in triplicate. The 
graph of hesperidin treatment demonstrated a biphasic effect on cell viability. The experiments were 
carried out three times, and the graph represents means ± SD (n=3). Statistical significance was determined 
by means of the Student’s t-test. Hash tags indicate significant increase (#; p<0.05) on cell viability 
compared with the control. Asterisks indicate a significant decrease (***; p<0.001 ****; p<0.0001) in cell 
viability compared with the control.  
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viability by as much as 61% and 10% at 250μM and 
500μM, respectively. These data confirmed the 
biphasic effect of Citrus extract on cell 
proliferation, and that effect was likely caused by 
its citrus flavonoid content.  
 
Citrus extract has a lower IC50 value compared 
with hesperidin in RAW 264.7 cells 
IC50 values were calculated based on linear 
regression equations derived from the graph of 
concentration versus cell viability (Figure 3).                  
The IC50 of Citrus extract and hesperidin was               
756 g/mL and 203μg/mL (332μM), respectively, 
as expected ranging at the high tested 
concentration. The IC50 of Citrus extract was 3.7 
times higher than that of hesperidin. This is 
plausible because Citrus extract may contain other 
compounds. Nevertheless, at the given IC50, studies 
on the utilization of Citrus extract rather than 
hesperidin may yield additional advantages, 
especially if the accessibility of a pure compound is 
limited. 
 
 
 
Figure 3. The IC50 value of Citrus extract or 
hesperidin in RAW264.7 macrophage cells. Cells 
were treated with a concentration series of Citrus 
extract (A) or hesperidin (B) for 24h and then 
assayed by the MTT method. Graphs of 
concentration versus percentage cell viability are 
presented as indicated. Points in A and B are 
presented as the mean of two or three experiments, 
respectively. The IC50 value was calculated by linear 
regression analysis as stated on each graph.  
 
Citrus extract can induce IL-10 expression 
Treatment with 250μg/mL Citrus extract 
induced expression of IL-10, an anti-inflammatory 
cytokine, indicated by a brownish color in the 
cytoplasmic area compared with control IgG 
(Figure 4, rightmost panel versus leftmost panel). 
However, at a concentration of 25μg/mL, Citrus 
extract did not affect IL-10 expression and 
appeared similar to cells without Citrus extract 
treatment (0μg/mL). Higher concentrations should 
be tested further to confirm whether the 
modulation of IL-10 expression caused by Citrus 
extract is also ensuing the biphasic trend. 
 
 
 
Figure 4. Effects of Citrus extract treatment on the 
expression of interleukin-10 (IL-10). Cells were 
incubated with Citrus extract at the indicated 
concentrations for 15h. Cells were immunostained 
for IL-10 (brown) and counterstained with Mayer’s 
hematoxylin to visualize nuclei (blue). Staining 
without primary antibody served as a control 
(leftmost panel). Scale bar = 50μm. 
 
Our findings exhibit that the ethanolic 
extract of Citrus reticulata (Citrus extract) and 
hesperidin, a citrus flavonoid, display a biphasic 
effect on the proliferation of a monocyte 
macrophage cell line, indicated by the cell viability 
parameter (Figure 1B and 2). More importantly,  
the concentration of Citrus extract required to 
increase RAW 26.7 cell viability varied from 
1μg/mL to 250μg/mL (Figure 1B) compared with 
10-1,500μg/mL in cancer cell lines ( Yunas et al., 
2007; Ardiani et al., 2008; Puspita et al., 2008). 
Meanwhile, hesperidin at low concentrations 
(5−100μM) can increase cell viability (Figure 2), 
similarly in cancer cell lines (5–100 or 200μM) 
(Hermawan et al., 2010; Gilang et al., 2012). The 
IC50 value of hesperidin in the monocyte 
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macrophage cell line is 1.7–30 times higher than in 
cancer cell lines (Figure 3B) (Kusharyanti et al., 
2011; Setiawati et al., 2011; Febriansah et al., 
2014). Taken together, the use of Citrus extract or 
hesperidin should carefully deliberate the 
concentration or dosage and the cell type.  
Macrophages express interleukin-10 (IL-10) 
and usually triggered by inflammatory stimuli 
(Chung  et al.,  2007).  Since   citrus   flavonoids   has 
been studied extensively for their anti-
inflammatory activity (Manthey et al., 2001), it is 
plausible to observe IL-10 expression under Citrus 
extract or hesperidin treatments. Due to our 
limitations (Figure 4). At 250μg/mL, Citrus extract 
can induce IL-10 expression, but not at lower 
concentrations. In the future study, higher 
concentrations of Citrus extract should be tested to 
confirm whether the modulation of IL-10 
expression caused by Citrus extract also follows the 
pattern of a dual effect. Furthermore, the 
expression of cyclooxygenase-2 (COX-2), one of the 
key enzymes in inflammation, was also tested. 
However, there was no COX-2 detected (data not 
shown). An inflammatory stimulus such as 
lipopolysaccharide (LPS) should be administered 
to the cells, similarly to the ones that have been 
reported previously (Kang et al., 2011; Sakata et al., 
2003). 
At lower concentrations, Citrus extract was 
able to maintain cell viability independently of the 
expression of the anti-inflammatory cytokine IL-
10. Meanwhile, hesperidin at a lower concentration 
was able to promote cell proliferation. Therefore, a 
low concentration of Citrus extract and hesperidin 
is possibly useful for treating inflammatory 
diseases. On the other hand, application of a low 
concentration of Citrus extract or hesperidin should 
be avoided for cancer cells because it induces cell 
proliferation as previously reported in a colon 
cancer cell line by Ardiani et al. (2008). 
Alternatively, at higher concentrations, Citrus 
extract or hesperidin is beneficial to cancer cells 
due to their cytotoxic effects. Recently, genistein, 
another flavonoid found in soybean, a widely 
known potential chemopreventive agent, has been 
reported to demonstrate a biphasic mechanism on 
CHO-K1 cells: at low concentrations, it induces 
senescence and apoptosis in combination with 
estrogen, and at high concentrations, it modulates 
the cell cycle (Jenie et al., 2019). Hence, an 
investigation of the dose-dependent mechanism of 
Citrus extract and hesperidin should be carried out 
further.    
              
CONCLUSION 
Citrus extract and hesperidin exerted                         
a biphasic effect on a macrophage cell                             
line. The future development of Citrus extract               
as a co-chemotherapeutic, anticancer, or 
immunemodulatory agent should include                  
careful consideration of its biphasic effect on each 
cell type. 
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